Featured Research

from universities, journals, and other organizations

Gestational diabetes associated with declining cognitive function

Date:
June 23, 2014
Source:
Endocrine Society
Summary:
Women who develop diabetes during pregnancy, called gestational diabetes, perform worse on cognitive function tests than do women with a normal pregnancy, according to a new study. "This is the first study that has associated a decline in cognitive function with gestational diabetes mellitus, which is an early diabetic state that raises the risk of Type 2 diabetes later on," the lead investigator said. "Based on our results, cognitive dysfunction in diabetes may begin early in the disease."

Women who develop diabetes during pregnancy, called gestational diabetes, perform worse on cognitive function tests than do women with a normal pregnancy, according to a new study from Turkey. The results were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.

Type 2 diabetes has been linked to accelerated cognitive, or brain-related, decline and an increased risk of dementia in elderly individuals. However, exactly when the memory problems can begin during diabetes is unclear, said the study's lead investigator, Ela Keskin, MD, of Istanbul University Cerrahpasa Medical Faculty.

"This is the first study that has associated a decline in cognitive function with gestational diabetes mellitus, which is an early diabetic state that raises the risk of Type 2 diabetes later on," Keskin said. "Based on our results, cognitive dysfunction in diabetes may begin early in the disease."

"Maybe with early interventions and therapies, the cognitive impairment in diabetes can be delayed," she said. "People at risk of Type 2 diabetes, especially women who had gestational diabetes, should be closely monitored by their doctor, and they need to control their weight and other risk factors for diabetes."

Keskin and her co-workers compared 44 women with gestational diabetes and 56 women with a healthy pregnancy who were similar in age, geographic location and educational level. According to Keskin, none of the subjects took medications other than insulin, including cholesterol-lowering statins, which have led to reports of confusion and forgetfulness in some users. Both groups reportedly had similar scores on a questionnaire regarding depression.

The women with gestational diabetes were slightly older than the other group, with an average age of 31 versus nearly 30 years, according to the abstract. At the start of pregnancy, they also had a higher body mass index (BMI), a measure of body fat based on height and weight. As expected, these women had much higher blood glucose, or sugar, levels.

Compared with the nondiabetic women, those who had gestational diabetes performed worse on several tests of cognitive function performed at the same week of pregnancy, the investigators reported. On a 30-point test that evaluates for mild cognitive impairment, called the Montreal Cognitive Assessment, the diabetic women had an average score three points lower: 21 points versus 24 points in women with a healthy pregnancy.

Women with gestational diabetes also had worse speed of mental activity and attention, as measured by the Symbol Digit Modalities Test, a test that measures the time to pair abstract symbols with specific numbers in 90 seconds. Their average score was about five points lower, indicating worse performance. In addition, they scored worse on the Spatial Recall Test 10/36, a visual memory test. Subjects see a checkerboard with 10 dots for 10 seconds and must replicate the pattern on a blank checkerboard, both immediately and 25 minutes later. For delayed recall, women with gestational diabetes scored worse: 4.5, on average, versus 5.4 in the nondiabetic group.

The researchers found that the higher the BMI and blood sugar levels, the lower the cognitive function. "Our results show an association of cognitive function with metabolic status," Keskin said.


Story Source:

The above story is based on materials provided by Endocrine Society. Note: Materials may be edited for content and length.


Cite This Page:

Endocrine Society. "Gestational diabetes associated with declining cognitive function." ScienceDaily. ScienceDaily, 23 June 2014. <www.sciencedaily.com/releases/2014/06/140623091947.htm>.
Endocrine Society. (2014, June 23). Gestational diabetes associated with declining cognitive function. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2014/06/140623091947.htm
Endocrine Society. "Gestational diabetes associated with declining cognitive function." ScienceDaily. www.sciencedaily.com/releases/2014/06/140623091947.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins